WHO Is Not Currently Advising Against Ibuprofen for COVID-19
To use or not to use ibuprofen in patients with novel coronavirus (COVID-19)—that is the question being juggled by pharmacists and other healthcare providers. Despite concerns raised in a recent clinical study published in The Lancet Respiratory Medicine, the latest is that the World Health Organization does not recommend against its use. Here is more information. 

FDA Issues New Guidance
on Compounding of Scarce
Hand Sanitizers
Pharmacy shelves have been emptied of hand sanitizers, and the FDA is trying to determine ways to ease the shortage and provide more protection against the novel coronavirus. One solution involves the easing of restrictions on compounding pharmacies. Find out what is and is not required now for pharmacies seeking to compound hand sanitizer.

Remdesivir Tested as Possible COVID-19 Treatment
What is remdesivir and why is it being touted as a possible treatment for COVID-19? The CDC recently provided information on the investigational drug, an IV medication with broad antiviral activity that inhibits viral replication through premature termination of RNA transcription, and how clinicians treating novel coronavirus patients can obtain it. Here is more information.